The company's platform includes a blunt injector that targets the back of the eye, overcoming technical challenges in effective suprachoroidal injection. Their technology offers drug delivery and distribution, with potential long-term therapeutic effects, improving patient compliance and outcomes. Everads Therapy is an early-stage life sciences company that aims to improve the efficacy and safety of existing and potential drug therapies for retinal and macular diseases. It operates within the RAD Biomed incubator in Tel Aviv, Israel, and has licensed its underlying technologies from the Sheba Medical Center at Tel Hashomer.